Počet záznamů: 1
Proteomic case studies of MDS in progression: heterogeneity and more heterogeneity
- 1.0013471 2023 RIV TR eng J
Pečánková, Klára - Čermák, Jaroslav - Májek, PavelG
Proteomic case studies of MDS in progression: heterogeneity and more heterogeneity.
Turkish Journal of Hematology. Vol. 39, no. 4 (2022), s. 272-274. ISSN 1300-7777
Grant: Grantová agentura ČR GA20-10845S
Institucionální podpora: RVO:00023736
Klíčová slova: MDS * plasma proteome * proteomics
Cite Score: 2.700, rok: 2022; SJR: 0.408, rok: 2022; IF: 2.6, rok: 2022
DOI: 10.4274/tjh.galenos.2022.2022.0290
Anotace: Myelodysplastic syndromes (MDS) are a diverse group of hematological disorders. Despite the heterogeneity, there are several characteristics shared (apoptosis, cytopenias, etc.). These transforms into acute myeloid leukemia (AML).
Počet záznamů: 1